Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

131I-TM-601 crosses blood-brain barrier in glioma patients

Nov. 12, 2007

Qnexa improves quality of life in obese subjects

Nov. 12, 2007

Long-term sitaxsentan monotherapy beneficial in pulmonary arterial hypertension

Nov. 12, 2007

First-in-man study of tafluposide determines MTD in cancer patients

Nov. 12, 2007

First identified mutation in the sarcosine dehydrogenase gene may be associated with sarcosinemia

Nov. 12, 2007

In vitro and in vivo activity of new 5-HT2C inverse agonist characterized in San Diego

Nov. 9, 2007

Abbott characterizes novel analgesic CB2 receptor agonist

Nov. 9, 2007

Dual H3 antagonist/SERT inhibitor in development at J&J for depression

Nov. 9, 2007

Systemically administered calpain inhibitor effective in animal models of SAH

Nov. 9, 2007

Arformoterol pharmacokinetics, QTc effects and dosing variability examined

Nov. 9, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...